Subversive Mental Health ETF Rating → Biden replacement revealed? (From Paradigm Press) (Ad) Free SANE Stock Alerts $24.12 0.00 (0.00%) (As of 03/27/2024) Add Compare Share Share RatingsStock AnalysisChartHoldingsRatingsStock AnalysisChartHoldingsRatings Subversive Mental Health ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.SANE Aggregate RatingModerate Buy2.73Holdings in SANE have an aggregate rating of Moderate Buy based on 169 analyst ratings issued in the past year covering 17 companies (73.5% of the portfolio).SANE Aggregate Price Target$36.5451.48% UpsideHigh Prediction$55.06Average Prediction$36.54Low Prediction$24.96Holdings in SANE have an aggregate price target of $36.54 and a range of $24.96 to $55.06 covering 17 companies (73.5% of the portfolio).SANE Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy10 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Subversive Mental Health ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 17 SANE Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings7.38%WSTWest Pharmaceutical Services$360.43-2.1%5 of 5 stars2.80$435.20 20.7%5Earnings ReportDividend AnnouncementEx-DividendAnalyst RevisionNews Coverage6.03%DXCMDexCom$124.34-9.9%5 of 5 stars2.93$141.67 13.9%14Earnings ReportAnalyst DowngradeOptions VolumeAnalyst RevisionNews CoverageGap DownHigh Trading Volume4.87%ARCTArcturus Therapeutics$26.55+1.5%2 of 5 stars3.00$61.33 131.0%74.85%ALKSAlkermes$24.68+1.0%5 of 5 stars2.50$35.38 43.3%10Upcoming EarningsShort Interest ↓4.69%LLYEli Lilly and Company$733.51+1.2%5 of 5 stars2.84$728.05 -0.7%19Upcoming Earnings4.60%SNYSanofi$49.13-0.5%3 of 5 stars2.17$55.00 11.9%5Short Interest ↓Analyst RevisionNews Coverage4.53%TWSTTwist Bioscience$31.54+1.5%3 of 5 stars3.00$36.40 15.4%4Upcoming EarningsNews Coverage4.40%SDGRSchrödinger$23.97+2.7%3 of 5 stars2.67$43.50 81.5%9Upcoming Earnings4.40%UTHRUnited Therapeutics$233.85-0.9%5 of 5 stars2.89$294.25 25.8%9Upcoming EarningsInsider Selling4.22%GSKGSK$41.11+0.5%2 of 5 stars2.405Upcoming EarningsShort Interest ↑News Coverage4.11%BIIBBiogen$208.90+3.2%5 of 5 stars2.67$293.88 40.7%27Earnings ReportAnalyst ReportShort Interest ↓Analyst RevisionNews Coverage4.09%REGNRegeneron Pharmaceuticals$883.20-0.8%5 of 5 stars2.70$977.77 10.7%20Upcoming EarningsAnalyst ReportAnalyst RevisionNews Coverage4.01%MRKMerck & Co., Inc.$131.20+0.4%5 of 5 stars2.58$131.33 0.1%12Earnings ReportAnalyst ReportAnalyst RevisionNews Coverage3.63%CMPSCOMPASS Pathways$7.94+1.0%1 of 5 stars3.00$47.40 497.0%5Short Interest ↑3.49%BDXBecton, Dickinson and Company$231.55+0.5%5 of 5 stars2.80$280.00 20.9%5Upcoming EarningsShort Interest ↓2.16%MDTMedtronic$79.74+0.6%5 of 5 stars2.40$94.91 19.0%102.06%DVADaVita$133.51+0.6%4 of 5 stars2.33$118.50 -11.2%3Upcoming EarningsAnalyst UpgradeShort Interest ↓News Coverage This page (BATS:SANE) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithProtect Your Bank Account Before It’s Too LateWeiss RatingsWhy Big Pharma is Investing Billions in This BiotechBehind the MarketsJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Subversive Mental Health ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
